An Nvidia logo can be seen on the company building in an industrial park on February 7, 2019 in Tianjin, China.
VCG | Visual China Group | Getty Images
CureVac – The German biopharmaceutical company's shares continued to fall after primary efficacy results were released on Wednesday for its Covid-19 vaccine candidate, which showed preliminary efficacy of only 47%. The stock closed 39% on Thursday.
Novavax – Novavax shares rose 2% after CureVac reported disappointing results from a study on its Covid-19 vaccine. Novavax said on Monday its Covid vaccine was 90% effective.
The Honest Company – The Honest Company's stock fell 7.37% after the baby and beauty business’s initial earnings report. The company had revenue of $ 81.0 million for the first quarter, compared to analyst estimates of $ 79.3 million, according to Refinitiv. Guggenheim downgraded the share from "Buy" to neutral. "While we remain positive on the underlying fundamental outlook, given the more balanced risk / reward ratio and lack of an obvious catalyst, we believe we are downgrading the stock to neutral to significantly raise our sales expectations or valuation multiples," said Guggenheim .
Nvidia – Nvidia shares rose 4.7% after Jefferies raised its target price on the semiconductor stock to a Wall Street high of $ 854. "We see NVDA as one of the main beneficiaries of the fourth tectonic shift in computing, with parallel processing gaining a share of the computing market," said Jefferies' Mark Lipacis. "We believe NVDA's decades of investment in CUDA have resulted in multi-year competitive advantage."
Lennar – The housing company's shares were up 3.6%. On Wednesday, Lennar reported earnings of $ 2.65 per share, according to Refinitiv, beating estimates of $ 2.36 per share. The company is grappling with higher production costs and a labor shortage, but the shortage of homes for sale in the U.S. helped raise prices and significantly increase Lennar's profit margins year over year.
Danaher – The medical device maker's stock rose about 4.5% after it was announced that it will buy privately held biotech company Aldevron for $ 9.6 billion in a cash-only deal. Aldevron produces plasmid DNA, mRNA and proteins to support biotechnology and pharmaceutical customers and has a contract with Moderna to supply plasmid DNA, a requirement for vaccine manufacturing.
Kroger – The supermarket chain's stock rose over 5% after reporting earnings, raising its earnings forecast, and making buybacks. Kroger reported earnings per share of $ 1.19, beating analyst estimates by 19% and revenue of $ 41.3 billion.
Fisker – The auto company's shares rose more than 3% after signing a long-term manufacturing agreement with Magna International. Production of the SUV Fisker Ocean is scheduled to begin in November 2022 at the climate-neutral Magna plant in Graz, Austria.
– CNBC's Hannah Miao and Maggie Fitzgerald contributed to the coverage
Become a smarter investor with CNBC Pro.
Get stock picks, analyst calls, exclusive interviews and access to CNBC TV.
Sign in to one. to start Try it for free today